| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 06/29/2004 | US6755914 Crystalline mixture solid composition and preparation thereof |
| 06/24/2004 | WO2004052903A1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof |
| 06/24/2004 | WO2004052902A1 Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof |
| 06/24/2004 | WO2004052901A1 Methods for producing alkyl polyglucosides or alkenyl polyglucosides containing carboxyl groups |
| 06/24/2004 | WO2004016632A3 Lincomycin derivatives possessing antibacterial activity |
| 06/24/2004 | WO2003104248A8 Derivatives of uronic (alkyl-d-mannopyranoside) acid, methods for the preparation thereof, and applications thereof |
| 06/23/2004 | EP1430903A1 Use of proteasome inhibitors for the treatment of viral infections |
| 06/23/2004 | EP0958301B1 Purification of polyol fatty acid polyesters using a mixing vessel with controlled mixing |
| 06/23/2004 | CN1154652C 5-imino-13-doxy anthracycline derivatives, their uses, and processes for preparing them |
| 06/23/2004 | CN1154499C 13-Deoxyanthracycline derivatives and processes for preparing them |
| 06/22/2004 | US6752981 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to the phosphorus in the c3n2p or c3o2p ring |
| 06/17/2004 | WO2004050677A1 Novel chemical compunds and their use |
| 06/17/2004 | WO2004050098A1 Freeze-dried preparation of stabilized anthracycline compound |
| 06/17/2004 | US20040116690 Lincomycin derivatives possessing antibacterial activity |
| 06/17/2004 | US20040116677 having a polymer backbone; a first pendent unit comprising a linking group connected to said polymer backbone and a saccharide moiety connected to said linking group |
| 06/17/2004 | US20040116460 Anticancer agents |
| 06/17/2004 | US20040116361 Antihelminthic anthraquinones and method of use thereof |
| 06/17/2004 | US20040115283 Administering parenterally a therapeutically effective amount of one or more arsenic compounds |
| 06/16/2004 | EP1427407A2 Fatty amine drug conjugates |
| 06/16/2004 | EP1144425B1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 06/16/2004 | EP1140127B1 Antiprotozoal saponins |
| 06/16/2004 | EP1064942B1 Sustained release preparation of a macrolide |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/16/2004 | CN1504474A Preparing method for neamine |
| 06/16/2004 | CN1504196A Use of glycyrrhizin and its derivatives as mcp-1 production inhibitors |
| 06/16/2004 | CN1153777C Process for preparing a charcoal-GM1 complex |
| 06/15/2004 | US6750332 Have valuable cosmetically and pharmaceutically useful properties, such as prostaglandin synthesis inhibition; salicin esters |
| 06/10/2004 | WO2004048396A1 Specific acylation of carbohydrate hydroxyls |
| 06/10/2004 | US20040110723 Modified psma ligands and uses related thereto |
| 06/09/2004 | EP1426380A1 Association compound of trehalose or maltitol with metal ion compound |
| 06/09/2004 | EP1425408A2 Chemo-enzymatic synthesis of sialylated oligosaccharides |
| 06/09/2004 | EP1196176B1 Use of beta-napthoquinone derivatives for the manufacture of a medicament having an inhibiting effect on the release of glutamate by the brain |
| 06/09/2004 | EP1007043B1 Method for treatment of cns-involved lysosomal storage diseases |
| 06/09/2004 | CN1503671A Agent for topical ophthalmic treatment of ocular inflammatory diseases |
| 06/09/2004 | CN1502617A Aromatic amides, preparation method and application as medicines |
| 06/08/2004 | US6747012 Crystalline anthracycline antibiotic and process for producing the same |
| 06/08/2004 | US6747010 NKT cell-activating agents containing α-glycosylceramides |
| 06/08/2004 | US6746696 Triterpene compositions and methods for use thereof |
| 06/03/2004 | WO2004045623A1 Inositolized phospholipids |
| 06/03/2004 | US20040106686 Antihelminthic anthraquinones and method of use thereof |
| 06/03/2004 | US20040106539 Agents for the treatment of viral infections |
| 06/03/2004 | CA2506084A1 Inositolized phospholipids |
| 06/02/2004 | EP1423356A2 Novel aminobenzoephenones |
| 06/02/2004 | CN1500794A Rose hip general extract and producing technology thereof |
| 06/02/2004 | CN1500793A Natural arbutin and extracting method thereof |
| 06/02/2004 | CN1152039C Benzo (b) thiepine-1, 1-dioxide derivatives, producing method thereof, combination containing the same and uses thereof |
| 06/02/2004 | CN1151795C Drugs containing sulfopyranosylacylglycerol derivatives |
| 06/01/2004 | US6743781 Glycerolipid compounds useful for the transfer of an active substance into a target cell |
| 06/01/2004 | CA2321542C Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated "agelagalastatin" |
| 05/27/2004 | US20040102617 Specific acylation of carbohydrate hydroxyls |
| 05/27/2004 | US20040102607 Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 05/27/2004 | US20040101932 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 05/26/2004 | EP1421942A1 Use of glycyrrhizin and its derivatives as RANTES inducers |
| 05/26/2004 | EP1421941A1 Phospholipid derivatives having a polyhydroxylated aliphatic carbocycle |
| 05/26/2004 | EP1421939A1 Sustained release preparation of a macrolide compound like tacrolimus |
| 05/26/2004 | EP1421093A1 Crystaline clindamycin free base |
| 05/26/2004 | EP1421092A1 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
| 05/26/2004 | EP1124815B1 Method for producing luteolin and luteolin derivatives |
| 05/26/2004 | EP0915819B1 Illudin analogs useful as antitumor agents |
| 05/26/2004 | CN1499976A Caloporoside derivatives, methods for prodn. thereof and their use |
| 05/26/2004 | CN1498623A Glycyrrhizic acid and its derivative used as RANTES inducer |
| 05/26/2004 | CN1150969C Liquid thickener for surfactant systems |
| 05/25/2004 | US6740663 Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 05/25/2004 | US6740640 Polymerase inhibitor; anticancer agent |
| 05/25/2004 | CA2277171C Purification of polyol fatty acid polyesters using a mixing vessel with controlled mixing |
| 05/25/2004 | CA2267059C Sordarin derivatives |
| 05/21/2004 | WO2004041828A1 Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer |
| 05/20/2004 | US20040097403 Linkable sialyl lewis x analogs |
| 05/20/2004 | US20040096893 Immobilization of a biomass by modifying silicon substrate |
| 05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419777A1 Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors |
| 05/19/2004 | EP1064294B1 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them |
| 05/19/2004 | CN1496740A Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 05/19/2004 | CN1496739A Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 05/19/2004 | CN1150201C L-arabino-disaccharides of anthracyclines, Process for their preparation, and pharmaceutical compositions containing them |
| 05/18/2004 | US6737441 Preventing or treating persistent chronic gastritis, ulcers and/or stomach cancer |
| 05/14/2004 | WO2004043944A1 Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same |
| 05/14/2004 | CA2462181A1 Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same |
| 05/13/2004 | WO2003088907A3 Isoflavone and triterpene glycosides from soybeans |
| 05/13/2004 | US20040092455 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 05/13/2004 | US20040091433 Chromene derivative |
| 05/13/2004 | DE10135098B4 Verfahren zur Herstellung von peracylierten 1-O-Glycosiden A process for the production of peracylated 1-O-glycosides |
| 05/12/2004 | EP1102592B1 Coumarin and related aromatic-based polymeric prodrugs |
| 05/12/2004 | EP1022284B1 Taxoid derivatives and process for producing the same |
| 05/12/2004 | EP0940409B1 Process for the preparation of sphingolipids and sphingolipid derivatives |
| 05/12/2004 | EP0910415B1 Fluoro-labelled anthracycline and anthracyclinone derivatives |
| 05/12/2004 | CN1494910A Medicine containing pulsatilla root extuact as active component for curing solid tumor |
| 05/12/2004 | CN1149219C New compounds for treatment of cancer |
| 05/12/2004 | CN1149082C Di-and trivalent small molecule selecting protein inhibitors |
| 05/11/2004 | US6734300 Purification using cationic ion exchange resins |
| 05/11/2004 | CA2279428C Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 05/06/2004 | WO2004037272A1 Dengue virus infection inhibitor |
| 05/06/2004 | WO2004031202A3 Condensed palatinose in hydrogenated form |
| 05/06/2004 | WO2004009038A3 Cosmetic preparations with antibacterial properties comprising glycyrrhetinic acid |
| 05/06/2004 | WO2003100036A3 Novel antiretroviral sulpholipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase |
| 05/06/2004 | WO2002090369A3 Method for the production of surface active agent mixtures |
| 05/06/2004 | EP1416026A1 SUGAR−DERIVED GELLANT FOR HYDROGEL FORMATION |
| 05/06/2004 | EP1414454A1 Paroxetine glycyrrhizinate |